Results 221 to 230 of about 22,884 (253)

POSB270 Does Orphan Drug Status Confer Any Benefits for Products Undergoing HTA Appraisal By NICE in England?

Value in Health, 2022
G Foxon, P Craddy, C Wilson
openaire   +1 more source

The Orphan Drug Products—Another Solution?

Drug Intelligence & Clinical Pharmacy, 1983
openaire   +1 more source

Developments Related to Orphan Drug Products

American Journal of Health-System Pharmacy, 1983
openaire   +1 more source

Orphan Drug Development in Cardiovascular Medicine

Circulation: Cardiovascular Quality and Outcomes, 2020
Muhammad Shahzeb Khan, Muthiah Vaduganathan, Javed Butler   +2 more
exaly  

Worldwide collaboration for orphan drug designation

Nature Reviews Drug Discovery, 2016
Segundo Mariz, Kerstin Westermark, Bruno Sepodes   +2 more
exaly  

New products highlight ambiguity of orphan drug law

Nature Biotechnology, 2003
openaire   +1 more source

Drug repositioning for orphan diseases

Briefings in Bioinformatics, 2011
Anil G Jegga, Cheng Zhu, Minlu Zhang
exaly  

Clinical pharmacology as a cornerstone of orphan drug development

Nature Reviews Drug Discovery, 2011
Edward Bashaw, Anne R Pariser, Christine E Garnett   +2 more
exaly  

The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?

Health Policy, 2010
Youwen Zhou
exaly  

The orphan drug pipeline in Europe

Nature Reviews Drug Discovery, 2016
Thomas Morel, Eline Picavet, Bruno Sepodes   +2 more
exaly